How Big Pharma is fighting Biden's program to lower seniors' drug costs

TRENTON, N.J. - Pharmaceutical giants are mounting a vigorous legal battle against President Biden’s plan to lower seniors’ prescription drug costs, urging federal judges here and around the country to invalidate a new program that aims to reduce the price of medications for high blood pressure, heart disease, cancer and diabetes. In a flurry of lawsuits, these drugmakers have blasted the government initiative as unconstitutional, defended their pricing practices and warned that regulation could

Related Keywords

Delaware ,United States ,Canada ,White House ,District Of Columbia ,Japan ,New Jersey ,Ohio ,Washington ,Texas ,Trenton ,Americans ,Colmf Connolly ,Ashley Parrish ,Steve Knievel ,Samir Deger Sen ,Bristol Myers Squibb ,Noel Francisco ,Zachary Baron ,Zahid Quraishi ,Kelly Bagby ,Yaakov Roth ,James Stansel ,Donald Trump ,Kevin King ,Lawyers For The Justice Department ,Commonwealth Fund ,Oneill Institute At Georgetown University ,Foundation Litigation ,Law Initiative ,Us Chamber ,Novartis ,Astrazeneca ,Supreme Court ,Novo Nordisk ,Johnson ,Us District Court ,President Biden ,Inflation Reduction Act ,Columbia While ,Inflation Reduction ,Public Citizen ,Health Policy ,O Neill Institute ,Justice Department ,First Amendment ,